Aggressiveness features and outcomes of true interval cancers: comparison between screen-detected and symptom-detected cancers.

scientific article

Aggressiveness features and outcomes of true interval cancers: comparison between screen-detected and symptom-detected cancers. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/CEJ.0B013E328354D324
P8608Fatcat IDrelease_np55momlazhkjebgucbbn5jnza
P698PubMed publication ID22584215

P50authorJordi BlanchQ39986711
María SalaQ50765473
Laia DomingoQ53099736
Cristiane Murta-NascimentoQ53099752
Xavier CastellsQ53099768
P2093author name stringAntonio Rueda
Maximino Redondo
Josep Maria Corominas
Sònia Servitja
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)21-28
P577publication date2013-01-01
P1433published inEuropean Journal of Cancer PreventionQ5412711
P1476titleAggressiveness features and outcomes of true interval cancers: comparison between screen-detected and symptom-detected cancers.
P478volume22

Reverse relations

cites work (P2860)
Q55346639Aggressive primary treatments with favourable 5-year survival for screen-interval breast cancers.
Q36235990Associations between sociodemographic and clinicopathological factors and breast cancer subtypes in a population-based study
Q34029529Evaluation of the interval cancer rate and its determinants on the Girona Health Region's early breast cancer detection program
Q34379532Impact of risk factors on different interval cancer subtypes in a population-based breast cancer screening programme.
Q40586607Longitudinal fluctuation in mammographic percent density differentiates between interval and screen-detected breast cancer
Q37316377Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study
Q29248325Opportunities for improving triple‐negative breast cancer outcomes: results of a population‐based study
Q89127386Organized screening detects breast cancer at earlier stage regardless of molecular phenotype
Q60044938Predicting interval and screen-detected breast cancers from mammographic density defined by different brightness thresholds
Q36118014Racial and Ethnic Disparity in Symptomatic Breast Cancer Awareness despite a Recent Screen: The Role of Tumor Biology and Mammography Facility Characteristics
Q37559069Reduction in interval cancer rates following the introduction of two-view mammography in the UK breast screening programme.
Q40416765Short-term and long-term survival of interval breast cancers taking into account prognostic features.
Q39465178The Role of Preoperative Magnetic Resonance Imaging in the Assessment and Surgical Treatment of Interval and Screen-Detected Breast Cancer in Older Women
Q33767364The epidemiology, radiology and biological characteristics of interval breast cancers in population mammography screening
Q38232148Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers.

Search more.